Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

DOP040: Postoperative surgical recurrence in Crohn’s Disease decreases significantly in the biologic eraECCO'17 Barcelona
Year: 2017
Authors: Beelen E.
Natural history, Ileo Caecal resection, Post operative medical management, Anti-TNF agents
Files: 1
DOP041: Prepouch ileitis after ileal pouch anal anastomosis for Ulcerative Colitis: Patterns of presentation and risk factors for failure of treatmentECCO'17 Barcelona
Year: 2017
Authors: Rottoli M.
Ileo anal pouch procedure, Post operative complications, Post operative medical management, Stricture dilatation
Files: 1
DOP043: High risk of pouch dysplasia in IBD-PSC patients following total proctocolectomyECCO'17 Barcelona
Year: 2017
Authors: Palmela C.
Ileo anal pouch procedure, Post operative medical management, Sclerosing Cholangitis, Dysplasia, Pouchoscopy
Files: 1
DOP044: Relationship between microbiota and development of early postoperative Crohn’s Disease recurrenceECCO'17 Barcelona
Year: 2017
Authors: Machiels K.
Microbiotica, natural history, Ileo caecal resection
Files: 1
DOP046: Genome-wide association study of baseline disease characteristics and response to Ustekinumab in moderate to severe Crohn’s DiseaseECCO'17 Barcelona
Year: 2017
Authors: Hart A.
Genetic factors, Pharmacogenetics, Ustekinumab
Files: 1
DOP047: Early fibrostenosis in Crohn’s Disease is associated with multiple susceptibility loci on Immunochip analysisECCO'17 Barcelona
Year: 2017
Authors: Holvoet T.
Genetic factors, Fibrosis, Genetics
Files: 1
DOP048: PROFILE trial: Predicting outcomes for Crohn’s Disease using a molecular biomarkerECCO'17 Barcelona
Year: 2017
Authors: Noor N.
Natural history, Genetics, T cell
Files: 1
DOP051: Serological biomarkers of tissue turnover can early identify responders to infliximab in Crohn’s DiseaseECCO'17 Barcelona
Year: 2017
Authors: van Haaften W.
Crohn's disease, Inflixmab, Fibroblast, Fibrosis, Mesenchymal cell
Files: 1
DOP055: Results of the Fifth Scientific Workshop of the ECCO (II): Clinical aspects of perianal fistulising Crohn’s Disease - The unmet needsECCO'17 Barcelona
Year: 2017
Authors: Gecse K.
MDT, Perianal disease, Perianal fistulae, Abscess
Files: 1
DOP056: Pathophysiology of perianal Fistulising DiseaseECCO'17 Barcelona
Year: 2017
Authors: Scharl M.
Perianal disease
Files: 1
DOP057: Perianal pediatric Crohn's Disease is associated with a distinct phenotype and greater inflammatory burdenECCO'17 Barcelona
Year: 2017
Authors: Assa A.
Crohn's disease, Disease activity Indices, Perianal fistulae, Perianal disease
Files: 1
DOP058: Does biologic therapy increase the risk for fistula-associated mucinous adenocarcinoma in long standing perianal Crohn’s Disease?ECCO'17 Barcelona
Year: 2017
Authors: Laureti S.
Perianal fistulae, Perianal disease, Colorectal cancer
Files: 1
DOP059: New human gut xenograft mouse model for intestinal fistulasECCO'17 Barcelona
Year: 2017
Authors: Bruckner R.
Perianal fistulae, Enteroenteric fistula, Immunology, Mouse Model
Files: 1
DOP060: Real-world treatment pathway visualizations show low use of biologic therapies in Crohn’s Disease and Ulcerative Colitis in the United StatesECCO'17 Barcelona
Year: 2017
Authors: Siegel C.
Anti-TNF agents, Corticosteriods, Patient choice, Thiopurines (AZA / MP)
Files: 1
DOP063: Serial tuberculin skin test improves the detection of latent tuberculosis infection in Inflammatory Bowel Disease patientsECCO'17 Barcelona
Year: 2017
Authors: Taxonera C.
Crohn's disease, Ulcerative colitis, Anti-TNF agents, Thiopurines (AZA / MP), Tuberculosis
Files: 1